pharmaphorum

SEPTEMBER 29, 2022

The disorder – driven by type 2 inflammation characterised by an antibody-based immune response – causes hard lumps or nodules to form on the skin that are so itchy they can lead patients to scratch themselves to the point of bleeding or pain. The post FDA clears Dupixent as first drug for rare skin disorder appeared first on.

Drugs 69

Drugs Immune Response Allergies Sales 69

pharmaphorum

AUGUST 13, 2020

How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic in better shape than ever. These are the brands that have clearly demonstrated emotional intelligence, that have shown emotional empathy to their target audience.

Branding 112

Branding Vaccine Vaccination Filler 112

The Pharma Data

FEBRUARY 8, 2021

due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. Dupixent ® total prescriptions (TRx) increased 65% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 18% despite fewer in-person physician visits which remain below the pre-COVID level. CHC down 3.0%

Sales 52

Sales Vaccine Vaccination Production 52

The Pharma Data

FEBRUARY 4, 2021

due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. Dupixent ® total prescriptions (TRx) increased 65% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 18% despite fewer in-person physician visits which remain below the pre-COVID level. CHC down 3.0%

Sales 52

Sales Vaccine Vaccination Production 52

The Pharma Data

APRIL 27, 2021

due to COVID related stocking in Q1 2020 and low demand for cough and cold brands in Europe. Dupixent ® total prescriptions (TRx) increased 51% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 16% despite fewer in-person physician visits which remain below the pre-COVID level. CHC decreased 7.3% In the U.S., Change at CER.

Sales 52

Sales Vaccine Vaccination Medicine 52

XTalks

MAY 2, 2024

Among these are Madrigal Pharmaceuticals’ resmetirom (branded Rezdiffra) , which secured FDA approval in March for the treatment of nonalcoholic steatohepatitis (NASH) and sotatercept (commercial name Winrevair) for pulmonary hypertension (PAH). Since January, the FDA has already signed off on more than a dozen novel drugs.

Drugs 52

Drugs FDA Approval Vaccine Vaccination 52

XTalks

SEPTEMBER 14, 2020

These companies include Moderna, a US biotech company which has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID), Oxford University who has partnered with AstraZeneca, and Johnson & Johnson, Merck and Pfizer. China’s COVID-19 Vaccine: Sinovac Biotech and CanSino Biologics.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92